BVDV Antibodies

Santa Cruz Biotechnology delivers a wide array of BVDV monoclonal antibodies for the detection and analysis of Bovine Viral Diarrhea Virus (BVDV) in various research applications. BVDV monoclonal antibodies support multiple techniques including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BVDV is a significant pathogen in cattle, leading to substantial economic losses in the livestock industry due to its impact on health and productivity. The virus can cause a range of clinical manifestations, including respiratory disease, reproductive failure, and immunosuppression, making it crucial for researchers to study its mechanisms and effects. Understanding BVDV's role in cattle health is essential for developing effective control strategies and improving herd management practices. Researchers worldwide rely on BVDV monoclonal antibodies to advance their investigations into viral pathogenesis and host immune responses. Current research focuses on identifying viral proteins and their interactions with host cells, which is vital for developing new therapeutic approaches. BVDV monoclonal antibodies enable precise detection and characterization of viral components in experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to enhance animal health and advance veterinary medicine through rigorous scientific investigation.